000 | 01213 a2200349 4500 | ||
---|---|---|---|
005 | 20250513084445.0 | ||
264 | 0 | _c19960307 | |
008 | 199603s 0 0 eng d | ||
022 | _a0893-7648 | ||
024 | 7 |
_a10.1007/BF02740695 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCampbell, D B | |
245 | 0 | 0 |
_aThe use of toxicokinetics for the safety assessment of drugs acting in the brain. _h[electronic resource] |
260 |
_bMolecular neurobiology _c |
||
300 |
_a193-216 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Proteins _xmetabolism |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aDrug Evaluation _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntestinal Absorption |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aN-Methyl-3,4-methylenedioxyamphetamine _xpharmacokinetics |
650 | 0 | 4 |
_aNeurotoxins _xpharmacokinetics |
650 | 0 | 4 |
_aPhenethylamines _xpharmacokinetics |
650 | 0 | 4 | _aSex Characteristics |
650 | 0 | 4 | _aSpecies Specificity |
773 | 0 |
_tMolecular neurobiology _gvol. 11 _gno. 1-3 _gp. 193-216 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02740695 _zAvailable from publisher's website |
999 |
_c8561041 _d8561041 |